Discover 1,289 paid clinical trials in Columbus, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Columbus hosts a variety of active clinical studies, including for conditions such as diabetes, asthma, and cardiovascular diseases. The city's prominent healthcare institutions are recruiting participants, both as healthy volunteers seeking paid research opportunities and individuals in need of trials for specific conditions, offering access to new and innovative treatments and therapies.
Filter
2
Filter results
Results: 1,289
Improving Uroflowmetry Interpretability: Evaluating the Impact of Patient Reminder Systems
for
Pelvic Organ Prolapse, Urinary Incontinence
Location: Columbus OH
Sponsor: Ohio State University
Sex: Female
Age: 18+
Code: NCT07692789
Recruiting
The Spine Phenome Project
for
Low Back Pain, Neck Pain
Location: Columbus OH
Sponsor: Ohio State University
Sex: All
Age: 18+
Code: NCT05776771
Recruiting
Soy Tomato Juice to Improve Outcomes in Pancreatitis
Location: Columbus OH, Ann Arbor MI, New Brunswick NJ
Sponsor: Ohio State University Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT07225491
Recruiting
Microfabricated Microcatheter Advantages in Middle Meningeal Artery Embolization: an Early Experience at a Single Center
for
Chronic Subdural Hematoma, Hemorrhage Brain
Location: Columbus OH
Sponsor: Ohio State University
Sex: All
Age: 18+
Code: NCT07324551
Recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
for
Intracerebral Hemorrhage
Location: Columbus OH, Cincinnati OH, Detroit MI, Chicago IL,
Sponsor: Joseph Broderick, MD
Sex: All
Age: 18 - 70+
Code: NCT07227246
Phase3, Recruiting
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
for
Symptomatic Genetic Dilated Cardiomyopathy
Location: Columbus OH, Cincinnati OH, Detroit MI, Chicago IL,
Sponsor: Kardigan, Inc.
Sex: All
Age: 18+
Code: NCT07210723
Phase2, Phase3, Recruiting
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
for
Non-Small-Cell Lung Cancer,
Location: Columbus OH, Detroit MI, Winchester VA,
Sponsor: ArriVent BioPharma, Inc.
Sex: All
Age: 18+
Code: NCT07185997
Phase3, Recruiting
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease